BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8008172)

  • 1. Sphenoid wing meningioma progression after placement of a subcutaneous progesterone agonist contraceptive implant.
    Piper JG; Follett KA; Fantin A
    Neurosurgery; 1994 Apr; 34(4):723-5; discussion 725. PubMed ID: 8008172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users.
    Boonkasemsanti W; Reinprayoon D; Pruksananonda K; Niruttisard S; Triratanachat S; Leepipatpaiboon S; Wannakrairot P
    Hum Reprod; 1996 Oct; 11 Suppl 2():115-23. PubMed ID: 8982753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
    Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced endothelial cell migratory signal production by endometrial explants from women using Norplant contraception.
    Subakir SB; Hadisaputra W; Siregar B; Irawati D; Santoso DI; Cornain S; Affandi B
    Hum Reprod; 1995 Oct; 10(10):2579-83. PubMed ID: 8567774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of progesterone receptor mRNA in the endometrium during the normal menstrual cycle and in Norplant users.
    Lau TM; Witjaksono J; Affandi B; Rogers PA
    Hum Reprod; 1996 Dec; 11(12):2629-34. PubMed ID: 9021364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norplant-2 subdermal contraceptive system: experience in Taiwan.
    Lee TY; Yang YS; Tseng LH; Ko TM; Hsu MC; Chuang SM
    J Formos Med Assoc; 1993 May; 92(5):446-50. PubMed ID: 8104598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-acting steroids provide new options.
    Netw Res Triangle Park N C; 1988; 9(3):1-3, 7. PubMed ID: 12315656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ulnar nerve injury associated with removal of Norplant implants.
    Smith JM; Conwit RA; Blumenthal PD
    Contraception; 1998 Feb; 57(2):99-101. PubMed ID: 9589836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate postpartum insertion of the norplant contraceptive device.
    Molland JR; Morehead DB; Baldwin DM; Castracane VD; Lasley B; Bergquist CA
    Fertil Steril; 1996 Jul; 66(1):43-8. PubMed ID: 8752609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keloid formation from levonorgestrel implant (Norplant System) insertion.
    Nuovo J; Sweha A
    J Am Board Fam Pract; 1994; 7(2):152-4. PubMed ID: 7857393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study.
    Sivin I; Campodonico I; Kiriwat O; Holma P; Diaz S; Wan L; Biswas A; Viegas O; el din Abdalla K; Anant MP; Pavez M; Stern J
    Hum Reprod; 1998 Dec; 13(12):3371-8. PubMed ID: 9886517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers.
    Polaneczky M; Slap G; Forke C; Rappaport A; Sondheimer S
    N Engl J Med; 1994 Nov; 331(18):1201-6. PubMed ID: 7935659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial endothelial cell proliferation in long-term users of subdermal levonorgestrel.
    Goodger AM; Rogers PA; Affandi B
    Hum Reprod; 1994 Sep; 9(9):1647-51. PubMed ID: 7530724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levonorgestrel contraceptive implants in female patients 14 to 21 years old.
    Suman VJ; Van Winter JT; Evans MP; Simmons PS; Jacobsen SJ; Manolis AL
    Mayo Clin Proc; 1998 Jan; 73(1):10-6. PubMed ID: 9443673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient satisfaction with a levonorgestrel-releasing contraceptive implant. Reasons for and patterns of removal.
    Haugen MM; Evans CB; Kim MH
    J Reprod Med; 1996 Nov; 41(11):849-54. PubMed ID: 8951137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and Progesterone Therapy and Meningiomas.
    Hage M; Plesa O; Lemaire I; Raffin Sanson ML
    Endocrinology; 2022 Feb; 163(2):. PubMed ID: 34935947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of contraceptive implant capsules for removal.
    Thurmond AS; Weinstein AS; Jones MK; Jensen JT; Nichols MD
    Radiology; 1994 Nov; 193(2):580-1. PubMed ID: 7972784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levonorgestrel subdermal implants. Contraception on trial.
    Frank ML; DiMaria C
    Drug Saf; 1997 Dec; 17(6):360-8. PubMed ID: 9429835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone-only contraception is associated with a shorter progression-free survival in premenopausal women with WHO Grade I meningioma.
    Harland TA; Freeman JL; Davern M; McCracken DJ; Celano EC; Lillehei K; Olson JJ; Ormond DR
    J Neurooncol; 2018 Jan; 136(2):327-333. PubMed ID: 29081037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.